Who are MEBO Wound Ointment (MEBO)'s main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): ON101 Cream, MEBO Wound Ointment, KeraStat® Gel application, Ozonated olive oil gel, Oleogel-S10, Betaine taurine PVP gel.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/mebo-wound-ointment-mebo.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

MEBO Wound Ointment (MEBO) — Competitive Intelligence Brief

MEBO Wound Ointment (MEBO) (MEBO Wound Ointment (MEBO)) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Topical wound healing agent. Area: Dermatology / Wound Care.

phase 3 Topical wound healing agent Dermatology / Wound Care Small molecule Live · refreshed every 30 min

Target snapshot

MEBO Wound Ointment (MEBO) (MEBO Wound Ointment (MEBO)) — Skingenix, Inc.. MEBO Wound Ointment promotes wound healing by creating a moist healing environment and stimulating tissue regeneration and epithelialization.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
MEBO Wound Ointment (MEBO) TARGET	MEBO Wound Ointment (MEBO)	Skingenix, Inc.	phase 3	Topical wound healing agent
ON101 Cream	ON101 Cream	Oneness Biotech Co., Ltd.	marketed	Topical wound healing agent	Fibroblast growth factor receptor (FGFR)
MEBO Wound Ointment	MEBO Wound Ointment	Skingenix, Inc.	marketed	Topical wound healing agent
KeraStat® Gel application	KeraStat® Gel application	The Metis Foundation	marketed	Topical wound healing agent
Ozonated olive oil gel	Ozonated olive oil gel	Suez Canal University	phase 3	Topical wound healing agent
Oleogel-S10	Oleogel-S10	Chiesi Farmaceutici S.p.A.	phase 3	Topical wound healing agent
Betaine taurine PVP gel	Betaine taurine PVP gel	Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia	phase 3	Topical wound healing agent

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Topical wound healing agent class)

Skingenix, Inc. · 2 drugs in this class
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia · 1 drug in this class
Chiesi Farmaceutici S.p.A. · 1 drug in this class
Oneness Biotech Co., Ltd. · 1 drug in this class
Suez Canal University · 1 drug in this class
The Metis Foundation · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). MEBO Wound Ointment (MEBO) — Competitive Intelligence Brief. https://druglandscape.com/ci/mebo-wound-ointment-mebo. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab